The changes are being made “to further align with corporate governance best practices,” CVS said. The three departing board members will not be replaced.
The changes will go into effect after the company’s annual shareholder meeting. The date of that meeting has not been set. Last year’s meeting was in May.
Richard Swift, former chairman of the board, director of CVS Health and CEO of Foster Wheeler, has reached the mandatory retirement age.
Richard Bracken, former chairman and CEO of Nashville, Tenn.-based HCA Healthcare, will retire from the board to pursue personal interests.
Mr. Bertolini, who became a director when CVS Health acquired Aetna, will not continue as a board member after the annual meeting. CVS said the integration with Aetna has been successful.
“We want to thank each of these highly accomplished individuals for their service to the company and wish them all the best in the future,” said board chairman David Dorman.
More articles on strategy:
Walmart expands standalone health center model
What’s next for the Camden Coalition after MIT study challenges core strategy
Optum’s strategy in Las Vegas reveals how it plans to rapidly expand
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.